Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency - PubMed (original) (raw)
Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
S L Waldrop et al. J Clin Invest. 1997.
Abstract
The highly regulated secretion of effector cytokines by CD4+ T cells plays a critical role in immune protection against pathogens such as cytomegalovirus. Here, we directly compare the frequency and functional characteristics of cytomegalovirus-specific CD4+ memory/effector T cells in normal and HIV+ subjects using a novel, highly efficient multiparameter flow cytometric assay that detects the rapid intracellular accumulation of cytokine(s) after short-term (6 h) in vitro antigen stimulation. Responses in this assay correlate precisely with independent measures of sensitization history (e.g., seroreactivity), and allow the simultaneous assessment of multiple cytokines in single effector T cells. Healthy HIV- individuals manifested an average of 0.71, 0.72, 0.38, and 0.06% CD4+ T cells responding to cytomegalovirus with gamma-IFN, TNF-alpha, IL-2, and IL-4 production, respectively, with the simultaneous production of gamma-IFN, TNF-alpha, and IL-2 being the most common effector phenotype. Significantly, overall cytomegalovirus-specific CD4+ effector frequencies were markedly higher among 40% of HIV+ subjects (2.7-8.0%), and demonstrated a predominately polarized gamma-IFN+/TNF-alpha+/IL-2-/IL-4- phenotype. In contrast, CD4+ effector frequencies for heterologous, nonubiquitous viruses such as the mumps virus were low or absent in the HIV+ group. These data suggest the existence of homeostatic mechanisms in HIV disease that selectively preserve memory T cell populations reactive with ubiquitous pathogens such as cytomegalovirus-likely at the expense of T cell memory to more sporadically encountered infectious agents.
Similar articles
- Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.
Waldrop SL, Davis KA, Maino VC, Picker LJ. Waldrop SL, et al. J Immunol. 1998 Nov 15;161(10):5284-95. J Immunol. 1998. PMID: 9820501 - Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.
Tilton JC, Luskin MR, Johnson AJ, Manion M, Hallahan CW, Metcalf JA, McLaughlin M, Davey RT Jr, Connors M. Tilton JC, et al. J Virol. 2007 Mar;81(6):2713-25. doi: 10.1128/JVI.01830-06. Epub 2006 Dec 20. J Virol. 2007. PMID: 17182676 Free PMC article. - Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.
Chawansuntati K, Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Kaewthip O, Sroysuwan P, Sirisanthana T, Suparatpinyo K, Wipasa J. Chawansuntati K, et al. Hum Vaccin Immunother. 2015;11(9):2253-65. doi: 10.1080/21645515.2015.1051275. Epub 2015 Jun 19. Hum Vaccin Immunother. 2015. PMID: 26091502 Free PMC article. - The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy.
Fernandez S, Stone SF, Price P, French MA. Fernandez S, et al. Clin Immunol. 2008 Aug;128(2):228-37. doi: 10.1016/j.clim.2008.03.517. Epub 2008 May 29. Clin Immunol. 2008. PMID: 18511344 - Memory-phenotype CD4+ T Lymphocytes: A Novel Therapeutic Target in Infectious or Autoimmune Diseases?
Kawabe T. Kawabe T. JMA J. 2022 Jul 15;5(3):298-306. doi: 10.31662/jmaj.2022-0048. Epub 2022 Jun 17. JMA J. 2022. PMID: 35992294 Free PMC article. Review.
Cited by
- Functional deficits of pertussis-specific CD4+ T cells in infants compared to adults following DTaP vaccination.
Sharma SK, Pichichero ME. Sharma SK, et al. Clin Exp Immunol. 2012 Sep;169(3):281-91. doi: 10.1111/j.1365-2249.2012.04613.x. Clin Exp Immunol. 2012. PMID: 22861368 Free PMC article. - Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation.
Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, Brenchley JM, Hill BJ, Roederer M, Douek DC, Koup RA. Casazza JP, et al. J Exp Med. 2006 Dec 25;203(13):2865-77. doi: 10.1084/jem.20052246. Epub 2006 Dec 11. J Exp Med. 2006. PMID: 17158960 Free PMC article. - Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load.
Oxenius A, Sewell AK, Dawson SJ, Günthard HF, Fischer M, Gillespie GM, Rowland-Jones SL, Fagard C, Hirschel B, Phillips RE, Price DA; Swiss HIV Cohort Study. Oxenius A, et al. J Clin Immunol. 2002 Nov;22(6):363-74. doi: 10.1023/a:1020656300027. J Clin Immunol. 2002. PMID: 12462336 - Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.
Fleury S, Rizzardi GP, Chapuis A, Tambussi G, Knabenhans C, Simeoni E, Meuwly JY, Corpataux JM, Lazzarin A, Miedema F, Pantaleo G. Fleury S, et al. Proc Natl Acad Sci U S A. 2000 May 9;97(10):5393-8. doi: 10.1073/pnas.97.10.5393. Proc Natl Acad Sci U S A. 2000. PMID: 10805798 Free PMC article. Clinical Trial.
References
- Science. 1993 May 28;260(5112):1273-9 - PubMed
- Immunol Today. 1993 Mar;14(3):107-11 - PubMed
- Immunol Today. 1993 Jul;14(7):338-9 - PubMed
- FEMS Immunol Med Microbiol. 1993 Jun;7(1):55-62 - PubMed
- Eur J Immunol. 1993 Nov;23(11):2972-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials